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We investigated the role of autophagy in atheroscle-
rosis. During plaque formation in mice, autophagic
markers colocalized predominantly with macro-
phages (mf). Atherosclerotic aortas had elevated
levels of p62, suggesting that dysfunctional autoph-
agy is characteristic of plaques. To determine
whether autophagy directly influences atherogen-
esis, we characterized Beclin-1 heterozygous-null
and mf-specific ATG5-null (ATG5-mfKO) mice,
commonly used models of autophagy haploinsuffi-
ciency and deficiency, respectively. Haploinsufficent
Beclin-1 mice had no atherosclerotic phenotype, but
ATG5-mfKO mice had increased plaques, suggest-
ing an essential role for basal levels of autophagy in
atheroprotection. Defective autophagy is associated
with proatherogenic inflammasome activation. Clas-
sic inflammasome markers were robustly induced in
ATG5-null mf, especially when coincubated with
cholesterol crystals. Moreover, cholesterol crystals
appear to be increased in ATG5-mfKO plaques,
suggesting a potentially vicious cycle of crystal
formation and inflammasome activation in autoph-
agy-deficient plaques. These results show that au-
tophagy becomes dysfunctional in atherosclerosis
and its deficiency promotes atherosclerosis in part
through inflammasome hyperactivation.
INTRODUCTION
Autophagy is themechanism by which cytoplasmic components
such as organelles and protein aggregates are broken down and
recycled via the lysosomal apparatus (reviewed in Kundu and
Thompson, 2008). During periods of starvation, autophagy
promotes survival by degrading the cytoplasm in bulk, whereas
during nutrient excess, autophagy acts to selectively remove
damaged organelles (Klionsky and Emr, 2000; Kundu and534 Cell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc.Thompson, 2008). This process is highly evolutionarily
conserved, but mammalian organisms have also adapted au-
tophagy for more diverse uses such as clearance of pathogens
and coordination with apoptosis (Levine et al., 2011; Maiuri
et al., 2007). Autophagy is relevant to human disease. Defects
in autophagy have been implicated in the pathogenesis of
cancers, neurodegenerative diseases, heart failure, and inflam-
matory bowel disease (Komatsu et al., 2006; Kundu and Thomp-
son, 2008; Levine and Kroemer, 2008; Levine et al., 2011; Nakai
et al., 2007). Little is known about the role of autophagy in
atherosclerosis.
Limited evidence indicates that autophagy occurs in athero-
sclerosis, an expected finding given the presence of autophagic
markers in most organ systems. Transmission electron micros-
copy images of atherosclerotic plaques reveal structures consis-
tent with autophagosomes (Kockx et al., 1998; Martinet and De
Meyer, 2009), and certain marker proteins of autophagy have
been detected in atherosclerotic plaques by immunoblot or
immunohistochemical analysis (Martinet et al., 2004; Martinet
and De Meyer, 2009). The degree to which autophagy occurs
in plaque development, which cells in the atheroma contribute
to this process, andwhether autophagy impacts lesion formation
are unknown. Here, we address these issues using animals with
experimental atherosclerosis, ApoE-null mice. We found that
while most cells of the plaque have autophagic markers, macro-
phages appear to be most active at this process, and that au-
tophagy becomes dysfunctional with plaque progression. We
show that complete disruption of macrophage autophagy, but
not partial disruption, increases plaque formation. Mechanisti-
cally, this process in part involves hyperactivation of the macro-
phage inflammasome and excess IL-1b production. In the
autophagy-deficient setting, cholesterol crystals, a hallmark of
atherosclerotic plaques, become potent stimuli for inflamma-
some activation.RESULTS
Progressive Atherosclerosis Has Features
of Dysfunctional Autophagy
Autophagy is dynamic with autophagosome formation, cargo
sequestration, and eventual lysosomal fusion/degradation
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Figure 1. Assessment of Autophagy in the Atherosclerotic Plaque
(A and B)Western blot analysis of p62 and Beclin-1 in whole aorta lysates fromwild-type (WT, n = 4) and ApoE-null (n = 5) mice fed a western diet for 2 months (A),
and ApoE-null mice of increasing age (10 to 60 weeks; B). Densitometric quantification is shown below each respective western blot. Data are presented as
mean ± SEM. *p < 0.05; NS, not significant.
(C and D) Immunofluorescence microscopy of aortic root frozen sections from an ApoE-null mouse fed a western diet for 2 months.
(C) In all quadrants, p62 stains (red) and Hoechst-33258 nuclear stains (purple) are shown. Green stains are as follows: MOMA-2 (upper-left panel), CD11b (lower-
left panel), aSMC-Actin (upper-right panel), and CD45 (lower-right panel).
(D) Similar stains to (B), except with LC3/ATG8 staining (red) instead of p62. For all panels, the smaller individual stains for each protein (labeled) are shown on the
left, and a larger merged image is shown on the right.
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Autophagy and Atherosclerosisoccurring in rapid succession. Not surprisingly, there are no ideal
techniques for assessing autophagy flux in vivo (Klionsky et al.,
2008). However, p62/SQSTM1, a chaperone that shuttles intra-
cellular protein aggregates into autophagosomes for degrada-
tion, has emerged as a useful marker of autophagic status
(Bjørkøy et al., 2005; Klionsky et al., 2008; Komatsu et al.,
2007; Mathew et al., 2009). Since the entire p62/SQSTM1-
protein aggregate complex is degraded after engulfment by
the autolysosome, p62/SQSTM1 levels are inversely correlated
with autophagic flux, i.e., increases in p62/SQSTM1 indicate
defective autophagy (Komatsu et al., 2007; Mathew et al.,
2009). We fed ApoE-null mice (known to be atherosclerosis
susceptible) and their wild-type counterparts (with normal
ApoE alleles, no defects in cholesterol metabolism, and thusCatherosclerosis resistant) a western diet for 2 months and as-
sessed p62 levels in aortic lysates. p62 protein was dramatically
increased in atherosclerotic aortas (Figure 1A), consistent with
the presence of defective autophagy. Levels of p62 messenger
RNA (mRNA) were not significantly increased in atherosclerotic
aortas and prolonged fasting (a known stimulus for induction of
autophagy) of these mice resulted in decreased levels of p62
protein in atherosclerotic aortas (data not shown), suggesting
that changes in aortic p62 protein reflect in vivo autophagy
status. To determine how plaque progression affects autophagy,
we prepared aortic lysates from ApoE-null mice over time since
atherosclerosis progresses with age in this model. p62 levels
rise with increasing age/plaque burden (Figure 1B). Protein levels
of Beclin-1, a component of the complex involved in initialell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc. 535
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Figure 2. Quantification of Atherosclerosis in the Beclin-Het Autophagy-Deficient Model
(A) Western blot analysis of Beclin-1, p62, and b-actin in whole aorta lysates from control (n = 3) and Beclin-Het (n = 3) mice each on an ApoE-null background fed
a western diet for 2 months. Densitometric quantification is shown to the right. Data are presented as mean ± SEM. *p < 0.05.
(B and C) Cohorts of control and Beclin-Het mice (number of mice shown) were placed on a western diet for 2 months and atherosclerotic area involvement was
determined by computer image analyses.
(B) Oil Red O-stained sections of aortic roots (representative aortic root sections are shown on the right).
(C) En face results for the total aorta and its regions (aortic arch, thoracic aorta, and abdominal aorta). Horizontal lines within the data sets represent means. NS,
not significant.
See also Figure S1.
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Autophagy and Atherosclerosisnucleation/formation of the autophagosome (Levine and
Kroemer, 2008), were not significantly different in these lysates
(Figures 1A and 1B), suggesting that any observed autophagy
effects in atherosclerosis might involve downstream compo-
nents of the autophagic pathway.
To determine which cells in atherosclerotic plaques express
autophagy markers, we characterized ApoE-null atherosclerotic
aortic roots by immunofluorescence. The autophagy markers
p62 (Figure 1C) and LC3/ATG8 (Figure 1D) were concurrently
imaged with MOMA-2 (an antibody that recognizes monocyte
macrophages), an antibody to CD11b (expressed predominantly
on monocyte macrophages), an antibody to a-smooth muscle
cell actin (specific for smooth muscle cells), or an antibody
directed to the panleukocyte marker CD45. Both p62 and LC3/
ATG8 colocalize with plaque leukocytes (Figures 1C and 1D,
lower-right panels) that are mostly of the monocyte macrophage
macrophage lineage, i.e., MOMA-2 or CD11b-positive cells
(Figures 1C and 1D, left panels). Smooth-muscle cells constitute
a small portion of these early atherosclerotic lesions and do not
appear to contribute significantly to the autophagic process
(Figures 1C and 1D, upper-right panels). These results suggest
that monocyte macrophages are the predominant cell type ex-
pressing autophagy markers in the plaque and are likely respon-
sible for progressive autophagy deficiency.536 Cell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc.Autophagy Haploinsufficiency Has No Effect on Plaque
Progression
To perturb autophagy in atherosclerosis, we first used Beclin-1/
ATG6 heterozygous-deficient (also known as Beclin-Het) mice.
These animals are haploinsufficient for autophagy in numerous
organ systems and have been used to assess the function of au-
tophagy in cancer and heart failure (Qu et al., 2003; Yue et al.,
2003; Zhu et al., 2007). Beclin-Het mice and their control coun-
terparts each on the ApoE-null background were fed a western
diet for 2 months. Protein levels of p62 were increased in aortic
lysates from Beclin-Hets, confirming deficiency in plaque au-
tophagy (Figure 2A). There was no genotype-specific effect on
body weight, serum lipids, or insulin sensitivity as gauged by
glucose and insulin tolerance tests (Figures S1A–S1C available
online). Surprisingly, the presence of a partial autophagy defect
in the Beclin-Het/ApoE-null animals did not affect the extent of
atherosclerosis assayed at the aortic root (Figure 2B) or in the
whole aorta en face (Figure 2C) as compared to Apo-null animals
that were wild-type at the Beclin locus.
Complete Deficiency of Macrophage Autophagy Is
Proinflammatory
One interpretation of the lack of effect of Beclin haploinsuffi-
cency on atherosclerosis is that the autophagy defect in this
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Figure 3. Comparison of the Proinflammatory
Response of Beclin-Het and ATG5-mfKO Macro-
phages
Experiments in (A)–(C) utilized cultured thioglycollate-eli-
cited peritoneal macrophages.
(A) Western blot analysis of ATG5, p62, Beclin-1, and LC3
expression in macrophages derived from control versus
ATG5-mfKO mice.
(B) Macrophages from control versus ATG5-mfKO mice
treated with LPS (100 ng/ml) for the indicated times
(in hours). Cell culture supernatants were assayed for IL-1b
(left) and TNF-a (right) concentration by ELISA.
(C) Experiments identical to (B) except with macrophages
from control versus Beclin-Het mice. Experiments were
performed in duplicate.
(D) Cohorts of control and ATG5-mfKOmicewere injected
intraperitoneally with LPS (3.5 mg/g) and serum IL-1b at
the indicated time points (in hours) was measured by
ELISA.
(E) Cohorts of control and ATG5-mfKO each on the ApoE-
null background were fed a western diet for 2 months.
Serum IL-1b concentration was analyzed by ELISA.
Data are presented as mean ± SEM. *p < 0.05 (exact
p value shown).
See also Figure S2.
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Autophagy and Atherosclerosismodel is inadequate to impact atheroma progression. To pursue
this notion, we compared macrophages from Beclin-Het mice
with those from macrophage-specific ATG5-null (ATG5-mfKO)
mice, cells with complete absence of an autophagy gene.
ATG5-null mf in vitro had the expected absence of ATG5 in
concert with dramatic increases in p62 levels and a loss of the
lipidated-LC3 band, both characteristic of complete autophagy
deficiency (Figure 3A).
The significant degree of autophagy deficiency in ATG5-null
mf also manifested itself functionally. After stimulation with
LPS, ATG5-null macrophages selectively secreted IL-1b, but
not TNF-a, at levels considerably greater than control macro-
phages (Figure 3B). In contrast, Beclin-Het macrophages failed
to secrete either cytokine at levels different from control macro-
phages (Figure 3C). This in vitro proinflammatory phenotype was
recapitulated in vivo since macrophage-specific ATG5-null mice
(ATG5-mfKO) robustly produced serum IL-1b in response to
LPS injection (Figure 3D). Even in the absence of LPS stimula-
tion, serum IL-1b levels were increased in ATG5-mfKO/ApoE-
null mice fed a western diet for 2 months as compared to
similarly treated ApoE-null mice with normal levels of macro-
phage ATG5 (Figure 3E). Other classic proinflammatory (TNFa)
and anti-inflammatory (IL-10) cytokines were not altered in the
serum (Figure S2), suggesting that ATG5 deficiency promotes
a specific proinflammatory state with metabolic stress.
ATG16L1-null macrophages, another model of autophagy defi-
ciency, also selectively hypersecrete IL-1b in response to LPS
(Saitoh et al., 2008).
Complete Deficiency of Macrophage Autophagy
Enhances Plaque Progression
To determine whether the absence of macrophage autophagy
affects atherosclerosis, we fed a western diet for 2 months to
ATG5-mfKOmice and control mice carrying ATG5 floxed allelesCin the absence of the Cre transgene each on an ApoE-null back-
ground. p62 levels were increased in the vasculature of the
ATG5-mfKO animals consistent with deficient plaque autoph-
agy (Figure 4A). There was no genotype-specific effect on
body weight, serum lipids, or insulin sensitivity (Figures S3A–
S3C). However, atherosclerotic lesions were increased in
ATG5-mfKO compared to controls as assayed by both aortic
root and whole-aorta en face techniques (Figures 4B and 4C).
The increased Oil red O staining seen in ATG5-mfKO lesions
(Figure 4B) suggested an increase in foam cells, usually of
macrophage origin. Indeed, staining aortic roots with MOMA-2
revealed a significant portion of the ATG5-mfKO plaque area
is composed of macrophages (data not shown). These observa-
tions are supported by a recent report demonstrating a role for
autophagy in cholesterol efflux and foam cell formation (Ouimet
et al., 2011). In this regard, we also observed a reduced capacity
for cholesterol efflux in ATG5-mfKO macrophages (Figure 4D).
Given the proinflammatory phenotype of ATG5-mfKO macro-
phages, we also assessed the degree of IL-1b in atherosclerotic
aortas from control and ATG5-mfKO animals. After 2 months of
western-diet feeding, a proatherogenic intervention leading to
overt plaque formation, IL-1b levels were markedly elevated in
ATG5-mfKO aortas (Figure 4E). In contrast, with chow diet
feeding, a condition under which atherogenesis is blunted,
IL-1b levels were not significantly altered (Figure 4F). Moreover,
aortic p62 levels were not significantly elevated on a chow diet
(Figure 4G), supporting the notion that autophagy deficiency in
plaques is associated with progressive macrophage infiltration
and atherogenesis.
Autophagy Deficiency Leads to Hyperactivation of the
Macrophage Inflammasome
To understand the mechanistic basis of increased atheroscle-
rosis in ATG5-mfKO mice, we returned to the proinflammatoryell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc. 537
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Figure 4. Quantification of Atherosclerosis in the ATG5-mfKO Autophagy-Deficient Model
(A) Western blot analysis of p62 and b-actin in whole aorta lysates from control (n = 4) and ATG5-mfKO (n = 4) mice (ApoE-null background) fed a western diet for
2 months. Densitometric quantification is shown at right. *p < 0.05.
(B andC) Cohorts of control and ATG5-mfKOmice (ApoE-null background, number of mice shown) were fed awestern diet for 2months and atherosclerotic area
involvement was determined by computer image analyses.
(B) Oil red O-stained sections of aortic roots (representative aortic root sections are shown on the right).
(C) En face results for the total aorta and its regions (aortic arch, thoracic aorta, and abdominal aorta). Horizontal lines within the data sets represent means.
*p < 0.05 (exact p value shown), NS, not significant.
(D) Cholesterol efflux to apoAI in AcLDL-loaded control and ATG5-mfKO peritoneal macrophages over an 8, 24, and 48 hr time course. *p < 0.05.
(E and F) Cohorts of control and ATG5-mfKO mice each on the ApoE-null background were fed a western diet (E) or a chow diet (F) for 2 months. IL-1b
concentration from whole aorta lysates was analyzed by ELISA.
(G) Western blot analysis of p62 and b-actin in whole aorta lysates from representative chow diet-fed mice with the densitometric quantification shown below.
*p < 0.05 (exact p value shown), NS, not significant.
For all panels, data are presented as mean ± SEM. See also Figures S3 and S4.
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Autophagy and Atherosclerosisphenotype of the macrophages in these animals. The hyperse-
cretion of IL-1b in response to LPS (Figure 3B) by ATG5-null
macrophages does not occur due to transcriptional effects since
message levels for IL-1b and TNF-a respond similarly to LPS in
ATG5-null and control macrophages (Figure S4). IL-1b protein
is processed from a precursor form to a mature, secreted form
through activation of caspase-1, the major effector of inflamma-
some action (Davis et al., 2011; Schroder et al., 2010). Thus,
selective hypersecretion of IL-1b is characteristic of inflamma-
some activation. Similar levels of pro-IL-1b were present in cell
lysates from both ATG5-null and control macrophages after
LPS treatment (Figure 5A, upper panels), but ATG5-null macro-
phages hypersecrete the active/truncated forms of both IL-1b
and the caspase-1 p10 subunit (Figure 5A, lower panels). There-538 Cell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc.fore, defects in autophagy due to ATG5 deficiency produce in-
flammasome hyperactivation resembling findings with defects
in autophagy due to ATG16L1 deficiency (Saitoh et al., 2008).
Inflammasome activation may be critical for atheroma
progression, various forms of crystalline/particulate materials
are potent stimuli for inflammasome activation, and recent find-
ings indicate that cholesterol crystals, a hallmark of atheroscle-
rotic plaques, trigger this process (Duewell et al., 2010; Rajama¨ki
et al., 2010). Treatment of ATG5-null macrophages with a combi-
nation of LPS and cholesterol crystals induced IL-1b secretion to
levels several-fold higher than LPS alone (Figure 5B). Cholesterol
crystal addition did not affect the phenotypic appearance of
macrophages in these experiments (data not shown). To confirm
that such robust secretion of IL-1b in the setting of autophagy
A
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Figure 5. InflammasomesAre Synergistically Activated byCholesterol Crystals andAreCharacteristic of Autophagy-DeficientMacrophages
Experiments in (A)–(E) utilized cultured thioglycollate-elicited peritoneal macrophages from control versus ATG5-mfKO mice (A–C and E) or ATG7-mfKO
mice (D).
(A) Macrophages were treated with or without LPS (100 ng/ml) for 12 hr. Western blot analysis of pro-caspase-1 and pro-IL-1b frommacrophage cell lysates (top)
and the cleaved/activated forms of caspase-1 (p10 subunit) and IL-1b secreted into the cell culture medium (bottom) are shown. Densitometric quantification of
western blots from two separate experiments is shown at right. *p < 0.05; NS, not significant.
(B) Macrophages were treated with or without LPS (100 ng/ml) or LPS (100 ng/ml) + cholesterol crystals (CC, 500 mg/ml) for the indicated times (in hours). Cell
culture supernatants were assayed for IL-1b concentration by ELISA. Experiments were performed in duplicate. *p < 0.05.
(C) Macrophages were treated with LPS + cholesterol crystals for 12 hr and ASC aggregation speck formation was determined by immunofluorescence
microscopy. Four representative merged stains of ASC (red ‘‘specks’’) and DAPI nuclear stains (blue) are shown for control and ATG5-mfKOmacrophages. The
percentage of cells staining positive for ASC is quantified on the right.
(D) Control and ATG7-mfKO macrophages were treated with LPS and LPS + cholesterol crystals for 12 hr. Cell culture supernatants were assayed for IL-1b
concentration by ELISA. Experiments were performed in duplicate. *p < 0.05.
(E) Macrophages were treated with LPS + cholesterol crystals for 12 hr in the presence or absence of a caspase-1 inhibitor, and cell culture supernatants were
assayed for IL-1b concentration by ELISA. Experiments were performed in duplicate. *p < 0.05.
(F) Bonemarrow-derived macrophages fromwild-type, NLRP3-null, or ASC-null mice were treated with LPS or LPS+cholesterol crystals for 12 hr and cell culture
supernatants were assayed for IL-1b concentration by ELISA. Experiments were performed in duplicate. *p < 0.05.
For all panels, data are presented as mean ± SEM. See also Figures S5 and S6.
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Autophagy and Atherosclerosisdeficiency was primarily an inflammasome-dependent process,
we conducted a series of complementary experiments. Although
LPS increases the transcription of certain components of the in-
flammasome, the transcriptional response is not altered in the
setting of autophagy deficiency (Figure S5). Stimulation of
ATG5-null macrophages with LPS and cholesterol crystals leads
to increased formation of apoptotic speck protein bodies (ASC
‘‘specks’’) (Figure 5C), a hallmark of inflammasome complex
formation and activation (Huang et al., 2009). Macrophages
from macrophage-specific ATG7-null mice, an independentCmodel of autophagy deficiency have similarly elevated IL-1b
responses to LPS and cholesterol crystals (Figure 5D). Chemical
inhibition of Caspase-1, the downstream effector of inflamma-
some activation, blunts IL-1b responses in macrophages (Fig-
ure 5E). Similarly, macrophages lacking either NLRP3 or ASC,
the primary components of the inflammasome complex, have
a highly diminished capacity to secrete IL-1b (Figure 5F).
Conversely, although induction of autophagy has been re-
ported to reduce IL-1b (Harris et al., 2011), this effect appears
to be independent of inflammasomes since induction ofell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc. 539
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Figure 6. Increased Cholesterol Crystal Burden and Reactive Oxygen Species in ATG5-mfKO Plaques Are Potential Mediators of Athero-
sclerotic Progression
(A) Confocal reflectance microscopy of formaldehyde-fixed frozen-section aortic roots from cohorts of western diet-fed control and ATG5-mfKO (ApoE-null
background) mice. Plaque cholesterol crystal burden was quantified by computer image analysis. Horizontal lines within the data sets represent means. *p < 0.05
(exact p value shown). Reflectance images for a representative area of the aortic root are shown on the right.
(B) Western blot analysis of p62, ATG5, b-actin, and LC3 expression in wild-type thioglycollate-elicited peritoneal macrophages incubated with cholesterol
crystals (500 mg/ml) for the indicated times (in hours).
(C) Determination of protein oxidation in western diet-fed control and ATG5-mfKO (ApoE-null background) whole-aortic lysates using the OxyBlot immunoblot
detection assay. Densitometric analysis of control (n = 3) and ATG5-mfKO (n = 3) mice is also shown. *p < 0.05.
(D) The use of another oxidative stress marker, Dihydroethidium (DHE) staining, in representative aortic root sections of mice. Higher-intensity nuclear fluo-
rescence is indicative of increased superoxide levels.
For all panels, graphical data are presented as mean ± SEM.
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Autophagy and Atherosclerosisautophagy in macrophages through nutrient depletion de-
creases cellular levels of both pro- and mature forms of IL-1b
in concert with reducing its secretion (Figure S6). This result,
using peritoneal macrophages and confirming the findings of
Harris et al. (2011), was limited to induction of autophagy. In
a different model system, bone marrow-derived macrophages,
induction of autophagy in combination with the NLRP3 agonist
nigericin promotes the unconventional secretion of IL-1b (Du-
pont et al., 2011). These data suggest that the effects of tempo-
rally discrete induction of autophagy on IL-1b responses are
complex and context dependent. However, our results indicate
that defective basal autophagy in mice with ATG5-null macro-
phages increases atherosclerosis and aortic IL-1b levels in
a manner that appears to involve the inflammasome.
Potential Mediators of Atherosclerotic Progression
Cholesterol crystals are a significant component of atheroscle-
rotic plaques and are also detectable in early lesions (Duewell
et al., 2010). Cholesterol crystal area as determined by reflec-
tancemicroscopywas increased in ATG5-mfKO atherosclerotic
lesions (Figure 6A). One interpretation of this finding is that the540 Cell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc.proinflammatory state of ATG5-null macrophages may be
perpetuated by the increased cholesterol crystal burden of
atherosclerotic plaques. Extracellular cholesterol crystals are
initially trafficked to the lysosomal compartment of the macro-
phage where they are inefficiently and partially dissolved for
downstream reesterification (Duewell et al., 2010; Kruth et al.,
1995; Rajama¨ki et al., 2010). Persistently undissolved crystals
remain trapped in the lysosomal compartment, where they
may render the lysosome and processes such as autophagy
dysfunctional (Duewell et al., 2010; Rajama¨ki et al., 2010).
Indeed, macrophages incubated with cholesterol crystals over
a 12 hr period show concomitant increases in p62 levels and
increased conversion of LC3-I to LC3-II, suggesting that
although some components of the autophagic process are not
affected, the final fusion/degradation step with the lysosome is
impaired (Figure 6B). Thus, cholesterol crystals have the ability
to incite inflammasome activation as well as block autophagic
processing.
One of the proposed mechanisms for inflammasome activa-
tion has been the presence of reactive oxygen species (ROS)
(Gross et al., 2011; Naik and Dixit, 2011). Thus, we looked for
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Figure 7. Schematic Depiction of the Links between Autophagy, Inflammasomes, and Atherosclerotic Progression
Deficient autophagy, through mechanisms that might include lysosomal leakage, generation of reactive oxygen species, and impaired mitophagy, results in
activation of the inflammasome. This process increases accumulation of cholesterol crystals, which may lead to a cycle of atherosclerotic propagation in the
setting of autophagy deficiency.
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Autophagy and Atherosclerosissignatures of ROS activation in the ATG5-mfKO atherosclerotic
plaques. Protein carbonylation, a marker of increased oxidative
modification of proteins (Stadtman, 1993), was significantly
elevated in atherosclerotic ATG5-mfKO aortas as assessed by
western blot analysis (Figure 6C). Similarly, dihydroethidium
(DHE) staining of atherosclerotic aortic roots, a measure of intra-
cellular superoxide levels, was increased in ATG5-mfKO pla-
ques (Figure 6D).
DISCUSSION
In this study, we provide evidence supporting a role for defective
autophagy in the pathogenesis of atherosclerosis. Progressive
plaque formation has features of defective autophagy predomi-
nantly related to plaque macrophages. A modest decrease in
plaque autophagy (Beclin-Het model) does not affect experi-
mental atherosclerosis but the loss of macrophage autophagy
(ATG5-mfKO model) accelerates atheroma progression. The
autophagy-deficient setting appears to exacerbate a cholesterol
crystal-mediated hyperactivation of the macrophage inflamma-
some with its proatherogenic IL-1b response. Links between au-
tophagy, the inflammasome, and atherogenesis are summarized
in Figure 7.
Atherosclerosis is complex, and our understanding of the
biology of proteins such as ATG5 is evolving. It is possible that
autophagy-independent roles of ATG5 might be involved in the
atherosclerotic phenotype of the ATG5-mfKO mice. However,
inflammasomes are involved in atherosclerosis (Duewell et al.,
2010), IL-1b secretion may indicate inflammasome activation
(Davis et al., 2011), and deficiencies of three distinct autophagy
proteins—ATG16L1 (Saitoh et al., 2008), ATG5 (Figure 5B) and
ATG7 (Figure 5D)—are associated with increased IL-1b secre-
tion. Collectively, these findings support the notion that autoph-
agy deficiency promotes atherosclerosis.
Cholesterol crystals, characteristic of atherosclerotic plaques,
activate inflammasomes, providing amechanistic basis for prop-Cagating atherogenesis (Duewell et al., 2010;Masters et al., 2011).
Our results indicate that intact autophagy suppresses the inflam-
masome, but the nature of this suppression is unclear. One
potential mechanism could involve the autophagic removal of
damaged mitochondria (also called mitophagy), in turn reducing
reactive oxygen species (ROS) production. Release of ROS and
DNA from damaged mitochondria can activate inflammasomes,
a process that is exacerbated in the absence of mitophagy (Naik
and Dixit, 2011; Nakahira et al., 2011; Zhou et al., 2011). The
observation that ATG5-mfKO plaques have increased markers
of protein oxidation and superoxide production lends credence
to this possibility. Also consistent with this notion, the saturated
fatty acid palmitate appears to inhibit autophagy while also
increasing mitochondrial ROS to induce inflammasome activa-
tion (Wen et al., 2011).
A second potential mechanism could involve the removal of
dysfunctional lysosomes (so-called lysosomophagy) (Klionsky
et al., 2007). Lysosomal destabilization, which promotes inflam-
masome activation, has been reported when poorly digestible
extracellular particulate matter (including cholesterol crystals)
is phagocytosed and shuttled to lysosomes for degradation
(Duewell et al., 2010; Hornung et al., 2008; Masters et al.,
2011). The proinflammatory nature of these dysfunctional lyso-
somes can be accentuated in the absence of lysosomophagy.
Additionally, evidence that cholesterol crystals affect the
progression of autophagy at the level of the lysosome serves
to further exacerbate this process. Given the broad range of
organelles and cellular components cleared by autophagy,
pleiotropic mechanisms may be coordinately activating the in-
flammasome in the setting of defective autophagy.
What degree of autophagy deficiency is proatherogenic? The
difference in phenotypes between the Beclin-Het and ATG5-
mfKOmice suggests that promotion of atherosclerosis requires
considerable disruption of constitutive plaque autophagy.
However, autophagy deficient states in humans would be
expected to be incompatible with life: all animal models ofell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc. 541
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Autophagy and Atherosclerosiswhole-body autophagy deficiencies described to date are either
embryonically or neonatally lethal (Komatsu et al., 2005; Kuma
et al., 2004; Saitoh et al., 2008). If, as suggested by our results
with Beclin-Het animals, autophagy heterozygosity in humans
is not proatherogenic, then severe defects in autophagy would
have to be acquired in order to impact human vascular disease.
Published evidence supports this possibility. Cells in athero-
sclerotic plaques develop progressive lysosomal dysfunction
with features resembling a lysosomal storage disease (Jerome,
2006). The accumulation of unhydrolyzed cholesteryl esters
and trapped/poorly translocated free cholesterol in lysosomes
has been described in macrophage foam cells (Brown et al.,
2000; Dhaliwal and Steinbrecher, 2000; Griffin et al., 2005;
Jessup et al., 1992; Lougheed et al., 1991; Yancey and Jerome,
2001). These unmetabolized substituents may impair the lyso-
somal degradation capacity of lipases, as well as other enzymes
including proteases. Our observation that p62 accumulates in
advanced atherosclerotic plaques is consistent with this
concept.
If acquired defects in plaque autophagy exacerbate athero-
sclerosis, inducing autophagy might be antiatherogenic. No
studies have addressed this notion directly. However, sirolimus
and everolimus, both inhibitors of the autophagy-suppressing
kinasemTORand thus classic stimulators of autophagy, are anti-
atherogenic inmice (Castro et al., 2004;Mueller et al., 2008; Pak-
ala et al., 2005; Zhao et al., 2009). Calorie-restricted mice,
another stimulus for autophagy induction (Wohlgemuth et al.,
2007), also have reduced atherosclerosis (Guo et al., 2002).
Atherosclerosis has been documented in humans who lived
1500 BCE (Allam et al., 2009), when epidemic obesity and
highly processed, nutrient-dense foods did not exist. Egyptian
scholars attributed vascular disease to ‘‘wekhedu,’’ undigested
food that accumulated in the vasculature to limit blood flow
and promote disease. Since deficient autophagy reflects an
inability to digest cellular food, our findings suggest that ancient
scientists may have been at least partially correct.
EXPERIMENTAL PROCEDURES
Animals
Protocols were approved by the Washington University Animal Studies
Committee. Beclin+/ (Beclin-Het) mice, a gift fromDr. Nathaniel Heintz, Rock-
efeller University (Yue et al., 2003), were backcrossed with ApoE/ mice
(C57BL/6 background) to generate Beclin+/ApoE-null and Beclin+/+ApoE-
null littermates used for experiments that were > N7 C57BL/6. Mice with the
floxed ATG5 locus, a gift from Dr. Noboru Mizushima, Tokyo Medical and
Dental University (Hara et al., 2006), were crossed with Cre-recombinase
transgenic mice under the control of the Lysosomal-M promoter and ApoE/
mice to generate mice with macrophage-specific ATG5 deficiency and litter-
mate controls that were > N7 C57BL/6. Beclin, ATG5,Cre, and ApoE genotyp-
ing was performed as previously described (Chakravarthy et al., 2005; Hara
et al., 2006; Yue et al., 2003). ATG7flox/flox, NLRP3/, and ASC/ mice
have been previously described (Hara et al., 2006; Mariathasan et al., 2004;
Sutterwala et al., 2006). Mice housed in a specific pathogen-free barrier facility
were weaned at 3 weeks of age to a standard mouse chow providing 6% calo-
ries as fat, then started on a western-type diet containing 0.15% cholesterol
providing 42% calories as fat (TD 88137, Harlan, Madison, WI) at 8 weeks
of age.
Analytical Procedures and Lesion Quantification
Serum IL-1b, whole-aorta IL-1b, and secreted IL-1b and TNF-a from culture
media were measured with ELISA assays from R&D Systems (MLB00B) and542 Cell Metabolism 15, 534–544, April 4, 2012 ª2012 Elsevier Inc.BD Biosciences PharMingen (559732). Cholesterol, triglycerides, glucose,
and free (nonesterified) fatty acids (FFA) were assayed in serum following a
4 hr fast as described (Li et al., 2000). Glucose tolerance and insulin tolerance
tests (GTT and ITT) were separated by at least 1 week with fasted mice that
were injected with 10% D-glucose (1 g/kg) or human regular insulin
(0.75 units/kg body weight, Eli Lilly and Co., Indianapolis, IN). Tail-vein blood
for these tests was assayed at 0, 30, 60, and 120 min using a glucose
meter (Contour, Bayer Healthcare, Mishawaka, IN). Serum TNF-a and IL-10
were measured with ELISA assays from BD Biosciences PharMingen
(559732) and R&D Systems (M1000). For assessment of IL-1b, TNFa,
NLRP3, ASC, and Caspase-1 transcript levels, extraction of total RNA, reverse
transcription, and quantitative RT-PCR were performed as described (Razani
et al., 2011). Sequences for the oligonucleotide primers used were designed
with the qPrimerDepot database (http://primerdepot.nci.nih.gov). Assays
were performed in duplicate and normalized to amplified mRNA for ribosomal
protein L32.
The en face and aortic root cross-section techniques previously described
(Semenkovich et al., 1998) were used to quantify atherosclerosis throughout
the aorta as well as at the vessel origin. En face regions were analyzed as
the aortic arch (from the aortic valve to the left subclavian artery), thoracic aorta
(from the left subclavian artery to the final intercostal arteries), and abdominal
aorta (from the intercostal arteries to the bifurcation of the iliac arteries).
Macrophage Culture and Inflammasome Stimulation
Macrophages were isolated essentially as described (Febbraio et al., 2000) by
injecting mice intraperitoneally with a 4% solution of thioglycollate media
(Sigma, St. Louis, MO) on day 1. On day 5, peritoneal macrophages were iso-
lated, washed, counted, and plated in DMEM with 10% FBS. Macrophages
were subsequently harvested at various times to isolate protein using standard
techniques. Cholesterol crystals were generated by subjecting cholesterol
powder (Sigma, St. Louis, MO) to an ethanol precipitation technique as
described (Rajama¨ki et al., 2010; Whiting and Watts, 1983). Time-course stim-
ulation with LPS (Sigma, St. Louis,MO) with or without cholesterol crystals was
performed as indicated in the respective figure legends. Chemical inhibition of
inflammasomeswas performedwith 10mMCaspase-1 inhibitor Z-YVAD-FMK
(Enzo Life Sciences, Farmingdale, NY).
Cholesterol Efflux
Experiments were performed as described with some modifications
(Schneider et al., 2010). In brief, 3H-labeled AcLDL was made by incubating
AcLDL (Invitrogen; 100 mg/ml) with 3H-cholesterol (American Radiolabel
Chemical; 2.5 mCi/ml) for 24 hr. Macrophages were labeled with 3H-labeled
AcLDL for 24 hr, equilibrated in 0.2% BSA for 12 hr, and incubated in the pres-
ence or absence of ApoAI (Invitrogen; 25 mg/ml) for an 8, 24, and 48 hr time
course. The ApoAI-dependent cholesterol efflux was determined as
a percentage of 3H-cholesterol in the media relative to total 3H-cholesterol in
the media and cells.
Western Blotting
Separation, transfer and blotting were performed as described (Razani et al.,
2001) with the following antibodies: p62/SQSTM1 (610832) from BD Biosci-
ences, San Diego, CA; b-actin (A2066) from Sigma-Aldrich, St. Louis, MO; Be-
clin-1 (H-300); Caspase-1 p10 (M-20) from Santa Cruz Biotechnology, Santa
Cruz, CA; LC3/ATG8 (NB100-2220); ATG5 (NB110-53818) from Novus Biolog-
icals, Littleton, CO; and IL-1b (AF-401-NA) from R&D Systems, Minneapolis,
MN. Detection of protein oxidation by western blotting was performed with
the OxyBlot Kit (Millipore, Billerica, MA) per the manufacturer’s instructions.
Microscopy
Immunofluorescence microscopy of frozen-tissue sections and paraformalde-
hyde-fixed macrophages was performed as previously described (Razani
et al., 2001). Studies included parallel experiments omitting primary or
secondary antibodies to validate specificity of the images. The following
primary antibodies were used: p62/SQSTM1 (GP62) from Progen Biotechnik,
Heidelberg, Germany; LC3/ATG8 (#2775) from Cell Signaling Technology,
Danvers, MA; MOMA-2 (MCA519G) from AbD Serotec, Oxford, UK; a-smooth
muscle actin (1A4 – FITC conjugate) from Sigma-Aldrich, St. Louis, MO;
CD11b (14-0112) and CD45 (14-0451) from eBioscience, San Diego, CA;
Cell Metabolism
Autophagy and Atherosclerosisand ASC (AL177) from Enzo Life Sciences, Plymouth Meeting, PA. Species-
specific fluoroprobe-conjugated secondary antibodies were obtained from
Invitrogen, Carlsbad, CA. Imaging of cholesterol crystals was performed
with reflectance microscopy (Zeiss LSM 510 confocal laser-scanning micro-
scope) essentially as previously described (Duewell et al., 2010). Crystal
area quantification was performed with ImageJ software (http://imagej.nih.
gov). Assessment of oxidative stress in aortic root frozen-tissue sections
was performed by fluorescence microscopy of dihydroethidium (DHE) stained
sections as previously described (Michel et al., 2011).
Statistical Analyses
Statistical significance of differences was calculated with the Student’s
unpaired t test for parametric data (in vitro macrophage experiments and
serummetabolites; GTT and ITT results) or theMann-Whitney test for nonpara-
metric data (atherosclerosis and cholesterol crystal quantitation). Graphs con-
taining error bars show the mean ± SEM.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and can be found with this
article online at doi:10.1016/j.cmet.2012.02.011.
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